Neurovance Lands $3,000,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=08ee848c-7af2-4887-a7c3-a530d7f6d8f3&Preview=1 - Date
10/16/2012 - Company Name
Neurovance - Mailing Address
43 Thorndike Street Cambridge, MA 02141 - Company Description
Neurovance is a stealth pharmaceutical company developing pharmaceutical preparations for the treatment of disorder of the central nervous system. - Website
Undisclosed
- Transaction Type
Debt - Transaction Amount
$3,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
The offering will close in 3 separate tranches if certain milestones are met. The first tranche of $3,000,000 closed 10/11/12. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
